emergencycollab

Tag: Johnson & Johnson MedTech

Uncategorized

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump

August 31, 2025

MADRID, Aug. 31, 2025 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) – Late breaking clinical science data, presented at the European Society of Cardiology (ESC) Congress today and simultaneously published in the New England Journal of […]

Continue Reading →

emergencycollab

Tag: Johnson & Johnson MedTech

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump

#Rosal Top Picks

ICEYE and Rheinmetall win main commitment virtue billions for area reconnaissance

Hormel Foods Announces Appointment of Jason Levine to New Enterprise-wide Chief Marketing Officer Position

Boundless Gadgets Appoints David Henry as Prominent Govt Officer

ICEYE and Rheinmetall win major contract worth billions for space reconnaissance

TCL mostrará el futuro con innovaciones visuales avanzadas en CES 2026

International Inexperienced Metal Marketplace to Develop at a 14.8% CAGR All over 2026-32

Petco Love Board Announces Chelsea Staley as New President

Recent Posts

ICEYE and Rheinmetall win main commitment virtue billions for area reconnaissance

Hormel Foods Announces Appointment of Jason Levine to New Enterprise-wide Chief Marketing Officer Position

Boundless Gadgets Appoints David Henry as Prominent Govt Officer

ICEYE and Rheinmetall win major contract worth billions for space reconnaissance

TCL mostrará el futuro con innovaciones visuales avanzadas en CES 2026

emergencycollab

Tag: Johnson & Johnson MedTech

#Rosal Top Picks

Market news

Recent Posts